# FDA EIR - Avella Specialty Pharma - July 26, 2012

Source: https://www.globalkeysolutions.net/records/eir/avella-specialty-pharma/5c9b5b98-21b8-4a52-a3de-fb529f683fa2

> FDA EIR for Avella Specialty Pharma on July 26, 2012. Product: Drugs. Access full analysis and detailed observations.

---

## Details

- Record Type: EIR
- Company Name: Avella Specialty Pharma
- Inspection Date: 2012-07-26
- Product Type: Drugs
- Office Name: Center for Drug Evaluation and Research

## Related Documents

- [483 - 2018-04-19](https://www.globalkeysolutions.net/records/483/avella-specialty-pharma/9992a004-56e1-4cf6-957f-d0a5b7fc4b6f)

## Related Officers

- [recipient](https://www.globalkeysolutions.net/people/david-k-perkins/0a6c6ef4-83e6-4044-b7cb-4ab2ef93a686)
- [company_representative](https://www.globalkeysolutions.net/people/keith-l-cook/0ca299ec-444a-4e3c-aac0-d02e86963663)
- [company_representative](https://www.globalkeysolutions.net/people/john-d-musil/66e9981b-a18b-455d-8b50-7b5ccb433902)
- [Kenneth Boehnen](https://www.globalkeysolutions.net/people/kenneth-boehnen/70d64816-c738-4864-87d3-9511cf314481)
- [company_representative](https://www.globalkeysolutions.net/people/marcella-solima/ad25497b-d699-4977-b724-889fa312faf0)

Company: https://www.globalkeysolutions.net/companies/avella-specialty-pharma/91841468-cdee-4834-83ae-c96ced353477

Office: https://www.globalkeysolutions.net/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c